Cite
Fang CH, Lin KY, Huang YC, et al. A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan. Value Health. 2014;17(7):A761-2doi: 10.1016/j.jval.2014.08.263.
Fang, C. H., Lin, K. Y., Huang, Y. C., & Liu, L. (2014). A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A761-2. https://doi.org/10.1016/j.jval.2014.08.263
Fang, C H, et al. "A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A761-2. doi: https://doi.org/10.1016/j.jval.2014.08.263
Fang CH, Lin KY, Huang YC, Liu L. A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan. Value Health. 2014 Nov;17(7):A761-2. doi: 10.1016/j.jval.2014.08.263. Epub 2014 Oct 26. PMID: 27202782.
Copy
Download .nbib
